Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Nicolas Gendron: Towards Sustainable Anticoagulation
Nov 18, 2026, 13:34

Nicolas Gendron: Towards Sustainable Anticoagulation

Nicolas Gendron, Postdoctorate research Fellow at Harvard Medical School, Research Fellow and Hematologist at Boston Children’s Hospital, shared a post on LinkedIn about recent articles, adding:

“New comment on our article about the carbon footprint of direct oral anticoagulants (DOACs) and our response with Victorien Monguillon in Haematologica Journal

The ecological transition in thrombosis and haemostasis also involves prescription choices, particularly for sustainable anticoagulation.

Readers shared their thoughts with us, especially regarding method and haemophilia treatment.

Thanks to everyone helping to advance the reflection on lower-carbon healthcare, without ever losing sight of quality of care for patients.”

Title 1: Response to Comment on: “Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism”

Authors: Nicolas Gendron, Victorien Monguillon

Read the Full Article on Haematologica Journal

Nicolas Gendron: Towards Sustainable Anticoagulation

Title 2: Environmental assessment of hemophilia therapies. Comment on: “Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism”

Authors: Manuel Rodríguez López , Michael Calviño Suárez

Read the Full Article on Haematologica Journal

Nicolas Gendron: Towards Sustainable Anticoagulation

Stay updated on all scientific advances with Hemostasis Today.